Ion-Channel-Targeting Scorpion Recombinant Toxin as Novel Therapeutic Agent for Breast Cancer
Toxins · 2025
DOI: 10.3390/toxins17040166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Natalia Mata de Los Rios und 8 weiteren Autor:innen. Beteiligte Einrichtung: Traslational Research Laboratory, Facultad de Medicina y Ciencias Biomédicas, Autonomous University of Chihuahua, Circuito Universitario s/n, Campus …. Hauptthemen laut MEDLINE: Scorpion Venoms, Breast Neoplasms, Antineoplastic Agents, Ion Channels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Autonoma de Chihuahua, Consejo Nacional de Ciencia y Tecnología (CONACyT), Universidad Autónoma de Chihuahua (UACh) research program +UACH, +Ciencia.
Abstract (Originalsprache)
Breast cancer remains the leading cause of cancer-related mortality among women worldwide, with limited therapeutic efficacy due to treatment resistance and adverse effects. Emerging evidence suggests that ion channels play crucial roles in tumor progression, regulating proliferation, apoptosis, migration, and metastasis. Voltage-gated potassium (Kv) and sodium (Nav) channels have been implicated in oncogenic signaling pathways. Scorpion venom peptides, known for their selective ion-channel-blocking properties, have demonstrated promising antineoplastic activity. This study explores the potential therapeutic applications of bioactive fractions derived from Chihuahuanus coahuilae, in breast cancer cell lines. Through chromatographic separation, mass spectrometry, and functional assays, we assess their effects on cell viability, proliferation, and ion channel modulation. Our preliminary data suggest that these venom-derived peptides interfere with cancer cell homeostasis by altering ion fluxes, promoting apoptosis, and inhibiting metastatic traits. These findings support the therapeutic potential of ion-channel-targeting peptides as selective anticancer agents. Further investigations into their molecular mechanisms may pave the way for novel, targeted therapies with improved efficacy and specificity for breast cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Traslational Research Laboratory, Facultad de Medicina y Ciencias Biomédicas, Autonomous University of Chihuahua, Circuito Universitario s/n, Campus II, Chihuahua 31125, Mexico.
- Facultad de Medicina y Ciencias Biomédicas, Autonomous University of Chihuahua, Circuito Universitario s/n, Campus II, Chihuahua 31125, Mexico.
- Instituto de Biotecnología-UNAM, Universidad Nacional Autónoma de México, Av. Universidad 2001, Col. Chamilpa, Cuernavaca 62210, Mexico.
- Laboratorio Nacional de Citometría de Flujo, Facultad de Medicina y Ciencias Biomédicas, Autonomous University of Chihuahua, Circuito Universitario s/n, Campus II, Chihuahua 31125, Mexico.
ORCID-Profile: Natalia Mata de Los Rios, Argel Gastelum-Arellanez, Herlinda Clement, Carolina Alvarado-González, Luis Carlos Hinojos-Gallardo, Gerardo Corzo, Gerardo Pável Espino-Solis
Förderung
- Universidad Autonoma de Chihuahua
- Consejo Nacional de Ciencia y Tecnología (CONACyT)
- Universidad Autónoma de Chihuahua (UACh) research program +UACH, +Ciencia
Zitieren
APA
Mata de Los Rios, N., Gastelum-Arellanez, A., Clement, H., Álvarez-Cruz, K., Romero-Terrazas, D., Alvarado-González, C., Hinojos-Gallardo, L. C., Corzo, G., & Espino-Solis, G. P. (2025). Ion-Channel-Targeting Scorpion Recombinant Toxin as Novel Therapeutic Agent for Breast Cancer. Toxins. https://doi.org/10.3390/toxins17040166
Vancouver
Mata de Los Rios N, Gastelum-Arellanez A, Clement H, Álvarez-Cruz K, Romero-Terrazas D, Alvarado-González C, et al. Ion-Channel-Targeting Scorpion Recombinant Toxin as Novel Therapeutic Agent for Breast Cancer. Toxins. 2025. doi:10.3390/toxins17040166
BibTeX
@article{MatadeLosRios2025,
author = {Mata de Los Rios, Natalia and Gastelum-Arellanez, Argel and Clement, Herlinda and Álvarez-Cruz, Karely and Romero-Terrazas, Diana and Alvarado-González, Carolina and Hinojos-Gallardo, Luis Carlos and Corzo, Gerardo and Espino-Solis, Gerardo Pável},
title = {Ion-Channel-Targeting Scorpion Recombinant Toxin as Novel Therapeutic Agent for Breast Cancer},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17040166}
}
EUVIMED